Navigation Links
Genesis Pharmaceuticals Files Counter Claims
Date:10/31/2008

LAIYANG, China, Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, was granted leave by the American Arbitration Association ("AAA") to amend its counterclaims and add claims for defamation and breach of contract in a contractual dispute with Capital Research Group Partners, Inc. and Capital Research Group, Inc. ("CRG&P"). The hearing date for the arbitration is set for December 1, 2008 in the AAA offices in Miami, Florida.

CRG&P recently issued a press release that Genesis alleges included numerous false and defamatory statements about Genesis and Genesis' officers and directors.

"We believe that CRG&P made false statements against us in an attempt to damage our Company's reputation. We plan to vigorously pursue our new counterclaims in the upcoming arbitration," stated Mr. Wubo Cao, Chairman and CEO of Genesis Pharmaceuticals Enterprises.

About Genesis Pharmaceuticals Enterprises, Inc.

Genesis Pharmaceuticals Enterprises, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Northeast China in an Economic Development Zone in Laiyang City, Shandong province. Genesis is a pharmaceutical company in China producing western and Chinese herbal-based medical drugs in tablet, capsule, and granule form.

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the Company's actual results and financial position to differ materially from those included w
'/>"/>

SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. EURYI project to understand how the brain wires during embryogenesis
3. DNA damage response confers a barrier for viral tumorigenesis
4. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
5. The genetics of MLL leukemogenesis
6. Genesis Technology Group Retains CCG Elite
7. Researchers chart the genetic mechanisms behind the genesis of fat cells
8. Tissue Genesis Signs Exclusive Distribution and License Agreement with SpineSmith
9. ThermoGenesis Corp. Reports First Quarter 2008 Results
10. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
11. Genesis Pharmaceuticals Announces Results for The First Quarter of Fiscal Year 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...e gestational glucose intolerance (a condition les...le cardiovascular risk factors as early as three m...ed for publication in The Endocrine Society,s Jou...M ). , Researchers in this study sought to eval...intolerance and postpartum risk of metabolic syndr...
(Date:12/1/2009)...Centers for Disease Control (CDC) estimates that 1... an autism spectrum disorder. These children can l...sing by playing the new therapeutic PC video game ...., a wonderful holiday gift idea for a child on th...a, MD (PRWEB) December 1, 2009 -- The new therapeu...
(Date:12/1/2009)...Newswire/ - Sentinelle Medical Inc., a leading man...alization software, extends its line of award winn...ty of North America (RSNA) annual meeting in Chica..., With the unique Vanguard(R) patient support d...Sentinelle,s line of breast coils are recognized f...
(Date:12/1/2009)...giving: Ready or Not helps families prepare for an... Cincinnati, Ohio (PRWEB) December 2, 2009... to help families understand and embrace the chall... our loved ones live long, healthy and prosperous ...e at some point, and their needs often become evid...
(Date:12/1/2009)... hearing aids will be given by Estes Audiology to ... Austin, TX (PRWEB) December 1, 2009 -...fessional hearing healthcare provider dedicated to...heir families, announced today the beginning of it... Each year, Estes Audiology donates two pairs of h...
Breaking Medicine News(10 mins):Health News:Glucose intolerance in pregnancy associated with postpartum cardiovascular risk 2Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 2Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 3Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 4Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 2Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 3Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2
...oratories Inc.,(NYSE: MYL ) today announced that ...oval from the U.S. Food and Drug Administration fo...Carvedilol Tablets, 3.125 mg,6.25 mg, 12.5 mg and ...lion for the 12 months ending June 30, 2007, for t...
... 10 percent of women with breast cancer stopped ta...nd muscle pain, according to a new study from rese...e Cancer Center. , The women in the study were ta...ven after surgery, chemotherapy or radiation thera...
...ank Farms, a national,ground beef producer, is vol...an Ground Round Beef Patties. The ground beef patt... been purchased by consumers in New,England on Wed...ut possible contamination with E.coli 0157:H7. Th...
...as, Inc. (NYSE:,VTR) ("Ventas" or the "Company") s...egular quarterly dividend of $0.475 per share, pay...s of record on September 17, 2007. The,dividend is...rust. Its,diverse portfolio of properties located ...
...gen starved environments have been used successful...py based anti-cancer treatments, according to scie...at the Society for General Microbiologys 161st Mee... radiotherapy and chemotherapy are ineffective, so...
...ger Co., a,wholly owned subsidiary of Siemens Corp...expiration date for its cash tender offer for all ... Holdings, Inc. (Nasdaq: DADE ). The,tender offer...d Plan of Merger, dated as of July 25, 2007, by an...
Other Medicine News:Health News:13 percent of women stop taking breast cancer drug because of side effects, U-M study finds 2Health News:13 percent of women stop taking breast cancer drug because of side effects, U-M study finds 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 4Health News:Bacteria successful in cancer treatment 2Health News:Siemens Extends Tender Offer for Acquisition of Dade Behring 2
(Date:12/1/2009)..., , MORRISVILLE, N.C., Dec. 1 /PRNewswi...der in the investigation of devices for minimally-...ounced the initiation of a feasibility clinical tr...f a combined surgical and catheter procedure, the ...atic paroxysmal atrial fibrillation (AF). This pr...
(Date:12/1/2009)..., , ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/...ics laboratory that discovers, develops and market...ppointment of Scott Glenn as chairman of the compa...r. ,, Prior to joining Exagen, Glenn was managi...er of a number of successful biomedical companies ...
(Date:12/1/2009)..., , BRIDGEWATER, N.J., Dec. 1 /PRNewswir... Ortho Biotech Products, L.P., announced today tha...ess of issues affecting women and people of color ...aign including local educational events, media out... the company is sharing learnings from the GRACE s...
Breaking Medicine Technology:nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference 13843 1WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference 13843 2WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference 13843 3European Urology September issue features Surgery in Motion article 56200 1NCI renews Fox Chase Penn Ovarian Cancer SPORE grant for a third 5 year term 56198 1NCI renews Fox Chase Penn Ovarian Cancer SPORE grant for a third 5 year term 56198 2NCI renews Fox Chase Penn Ovarian Cancer SPORE grant for a third 5 year term 56198 3NCI renews Fox Chase Penn Ovarian Cancer SPORE grant for a third 5 year term 56198 4
...h Health and,Roche Diagnostics Corporation have re...s in the growing field of molecular diagnostics. T...ertise in clinical testing,and care for patients w...che,s state-of-the-art technology to bring new dia...es are initially collaborating on the introduction...
...gene Target Discredited; Lower Dose, Array ...ffect, SAN DIMAS, Calif., Sept. 10 While the red... recently attracted scientific and,public attentio...e effects,of a calorie-restricted diet, the scienc...urn in recent months, according to Bill Sardi,spok...
Other Medicine Technology:National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities 2Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 2Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 3Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 4
ADVIA IMS 800i Integrated Modular System
VS II Standalone
PSD 1
... in providing versatile liquid handling platforms ...livers even more flexibility and possibilities for...er with the new easy-to-use software, Freedom EVOw...te genomics, proteomics, and drug discovery applic...
Medicine Products: